Japan in Biological Technology

"Over the Next 2-3 Years We Will Leverage Developmental Capabilities and Explore In-licensing and a Co-development Model to Consolidate Our Presence in Japan" - Dr. Kailash Sharma, President, Japan Operations, Zydus Cadila

TOKYO, July 30 /PRNewswire/ -- With a business plan to launch 8-10 new products each year, Nippon Universal Pharmaceutical Co. Ltd., a subsidiary of the Zydus group, one of India's leading integrated pharma companies & a global healthcare provider, is looking to give a big boost to its ope...

REMERON(R) Now Approved in Japan for the Treatment of Depression in Adult Patients

KENILWORTH, N.J., July 9 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP ) today announced that Schering-Plough K.K., the company's country operation in Japan, has received marketing approval for REMERON(R) /Reflex(R) (mirtazapine)15 mg Tablets for the treatment of major depress...

Microfluidics Expands Distributorship in Japan with Exclusive POWREX Partnership to Meet Increased Demand in Pharmaceutical, Biotechnology and Energy Industries

NEWTON, Mass., June 3 /PRNewswire-FirstCall/ -- Microfluidics, a wholly owned subsidiary of Microfluidics International Corporation (OTC Bulletin Board: MFLU), and POWREX Corporation have entered into an exclusive distributorship agreement whereby POWREX will market, sell and service Microfluidize...

SAFC Hitech & Air Water Inc. Extend High-End Materials Research Services Collaboration to Support Japan Chip Industry

Local R&D Capabilities Available To Accelerate Customer Development Programs; Agreement Underscores SAFC's Commitment to Japan 's Chip Market ST. LOUIS, April 28 /PRNewswire-FirstCall/ -- SAFC Hitech (R), a business segment within SAFC(R), a member of the Sigma-Aldrich(R) Group (...

2010 Japan Prize to Honor Scientists and Researchers in Industrial Production/Production Technology and Biological Production/Environment Fields

-Calling for nomination of candidates worldwide - TOKYO, Dec. 1 /PRNewswire/ -- The Science and Technology Foundation of Japan today announced the two fields eligible for the next Japan Prize, one of the world's most prestigious awards in science and technology. The 2010 Japan Prize will ...

Health Robotics Announces Strategic Partnership in Japan for its CytoCare(TM) Robot with TOSHO Inc.

BOZEN, Italy, November 10 /PRNewswire/ -- Health-Robotics today announced that TOSHO Inc., the global pioneer in Pharmacy Automation since 1971, has selected Health Robotics' CytoCare(TM) Robot after an extensive due diligence process undertaken by TOSHO's engineering and management teams, and...

Vical Licensee AnGes MG Files NDA in Japan for Collategene Angiogenesis Product

SAN DIEGO, March 28 /PRNewswire-FirstCall/ -- Vical Incorporated (Nasdaq: VICL ) today announced the company's licensee, AnGes MG, Inc., reported submission on March 27, 2008, of a New Drug Application (NDA) to the Japanese Ministry of Health, Labor and Welfare for its angiogenesis product ca...

American Scientists Named as Laureates of the 2008 (24th) Japan Prize

TOKYO, Jan. 17 /PRNewswire/ -- The Science and Technology Foundation of Japan announced the names of three laureates for the 2008 (24th) Japan Prize today. All three laureates this year are American scientists. They are Dr. Vinton Gray Cerf and Dr. Robert Elliot Kahn who received their award...

Shire's ELAPRASE(R) (idursulfase) Approved in Japan for the Treatment of Hunter Syndrome

BASINGSTOKE, England and CAMBRIDGE, Massachusetts, October 4 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY, TSX: SHQ) announced today that Japan's Ministry of Health, Labour and Welfare has approved ELAPRASE, a human enzyme replacement therapy for the treatment of Hunter syndrom...

Keryx Biopharmaceuticals, Inc. Enters into Licensing Agreement with Japan Tobacco and Torii Pharmaceutical for Development and Commercialization of Hyperphosphatemia Drug in Japan

Deal Includes up to $100MM in License Fees and Potential Milestone Payments NEW YORK, Sept. 26 /PRNewswire-FirstCall/ -- Keryx Biopharmaceuticals, Inc. (Nasdaq: KERX ), announced today that it entered into a licensing agreement with Japan Tobacco Inc. (JT) (TSE: 2914) and Torii Pharmaceutical C...

Environmental Tectonics Corporation's BioMedical Division Achieves Foreign Manufacturer Accreditation in Japan

SOUTHAMPTON, Pa., June 22 /PRNewswire-FirstCall/ -- Environmental Tectonics Corporation's (OTC Bulletin Board: ETCC) ("ETC" or the "Company") BioMedical Division today announced that the Japan Ministry of Health, Labor and Welfare (MHLW) has given accreditation to ETC as a foreign manufacturer in ...

Odyssey Thera Announces Collaboration With Mitsubishi Tanabe Pharma Corporation, and Issuance of Core Patent in Japan

SAN RAMON, Calif., May 15 /PRNewswire/ -- Odyssey Thera, Inc. announced today the initiation of a collaboration with leading Japanese pharmaceutical company Mitsubishi Tanabe Pharma Corporation. The alliance involves the analysis of drug candidates from a number of Mitsubishi Tanabe preclinical p...

Shire Announces Opening of Office in Japan

TOKYO, Japan and CAMBRIDGE, Massachusetts, February 20 /PRNewswire-FirstCall/ -- Shire plc (LSE: SHP, NASDAQ: SHPGY ), the global specialty biopharmaceutical company, announced today that it has officially opened a new representative office in Japan and has appointed Soh Fujiwara as Managing...

Romark and Chugai Pharmaceutical Enter Into Exclusive Licensing Agreement for Nitazoxanide in Japan

Chugai Pharmaceutical Gains Rights to Develop and Market Nitazoxanide for the Treatment of Chronic Hepatitis C TAMPA, Fla., Feb. 17 /PRNewswire/ -- Romark Laboratories, a privately held biopharmaceutical company, and Chugai Pharmaceutical Co. Ltd., a member of the Roche Group, today announced...

Align Technology Receives Expanded Regulatory Approval in Japan

SANTA CLARA, Calif., Dec. 8 /PRNewswire-FirstCall/ -- Align Technology, Inc. (Nasdaq: ALGN ) today announced that it has received regulatory approval from the Japanese Ministry of Health, Labour and Welfare (MHLW). The Company may now begin widespread marketing and promotion of Invisalign in Ja...

MaxCyte and Medinet to Present at the 10th International Symposium on Dendritic Cells in Kobe, Japan

"Tumor lysate electroloaded mature human DC exhibit enhanced antigen-specific potency compared to lysate co-incubation in clinical manufacturing scale" GAITHERSBURG, Md. and YOKOHAMA, Japan, Oct. 2 /PRNewswire/ -- MaxCyte, Inc. and Medinet Co., Ltd. (TSE: #2370) announce a joint poster prese...

ImmunoVaccine Technologies Broadens Its Patent Protection to Japan

HALIFAX, Aug. 5 /PRNewswire/ - ImmunoVaccine Technologies Inc. (IVT), a vaccine development company, today announced receipt of patent approval from the Japanese Patent Office for its vaccine platform. The specific patent, Vaccines with enhanced immune response and methods for their preparatio...

Spectral announces data on the clinical utility of EAA(TM) to be presented at 12th Annual Critical Care for Endotoxemia Conference in Japan

-Spectral joins leading Japanese medical centres in presenting data on clinical utility of EAA(TM) diagnostic- TORONTO, Feb. 28 /PRNewswire-FirstCall/ - Spectral Diagnostics Inc. (TSX: SDI) today announced that it will present new findings demonstrating the clinical utility of ...

Clexane(R)/Lovenox(R) Approved in Japan

PARIS, January 28 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today that the anticoagulant Clexane(R) (enoxaparin sodium injection) has been approved for marketing in Japan by the Ministry of Health, Labour and Welfare for the prevention of venous thromboembolism (VTE) in patients under...

Schering-Plough Announces Sugammadex New Drug Application Filed in Japan

KENILWORTH, N.J., Jan. 17 /PRNewswire-FirstCall/ -- Schering-Plough Corporation (NYSE: SGP ) announced that Nippon Organon K.K., now part of Schering-Plough, has filed a New Drug Application with the Japanese Ministry of Health, Labour and Welfare (MHLW) seeking marketing approval for its nov...

Masimo Corporation Given Approval to Market the Masimo Rad-57 Pulse CO-Oximeter in Japan

Masimo receives approval from Ministry of Health, Labor and Welfare (MHLW) for the revolutionary medical device that noninvasively measures carbon monoxide levels in the blood IRVINE, Calif., Nov. 27 /PRNewswire-FirstCall/ -- Masimo, the inventor of Pulse CO-Oximetry and ...

Neurocrine Biosciences and Dainippon Sumitomo Pharma (DSP) Announce Agreement to Develop and Commercialize Indiplon in Japan

SAN DIEGO, Nov. 1 /PRNewswire-FirstCall/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX ) today announced that it has entered into an exclusive licensing agreement for the development and commercialization of indiplon in Japan with Dainippon Sumitomo Pharma Co, Ltd. (DSP). Neurocrine has submi...

NPS Pharmaceuticals Announces Approval of Cinacalcet HCl in Japan

BEDMINSTER, N.J., Oct. 25 /PRNewswire-FirstCall/ -- NPS Pharmaceuticals, Inc. (Nasdaq: NPSP ) announced today the approval of cinacalcet hydrochloride by the Japanese Pharmaceuticals and Medical Devices Agency for the treatment of secondary hyperparathyroidism. As a result, NPS will receive a...

Genzyme Receives Approval to Market Elaprase(R) in Japan

CAMBRIDGE, Mass., Oct. 4 /PRNewswire-FirstCall/ -- Genzyme Corp. (Nasdaq: GENZ ) announced today that it has received approval to market Elaprase(R) (idursulfase) in Japan for the treatment of Hunter syndrome. Elaprase is an enzyme replacement therapy developed by Shire Human Genetic Therapie...

Exclusive Rights to Kuvan(TM) Data Licensed to Asubio Pharma in Japan

NOVATO, Calif., Sept. 17 /PRNewswire-FirstCall/ -- BioMarin Pharmaceutical Inc. (Nasdaq and SWX: BMRN) announced today that it has licensed to Asubio Pharma Co., Ltd. (a subsidiary of Daiichi Sankyo) exclusive rights to data and intellectual property contained in the Kuvan(TM) (sapropterin dih...

Medinet Licenses MaxCyte Cell Loading Technology for Cancer Immunotherapy in Japan

GAITHERSBURG, Md. and YOKOHAMA, Japan, Aug. 27 /PRNewswire/ -- MaxCyte, Inc. and Medinet Co., Ltd. (TSE: #2370) announced today the signing of an exclusive license, development and supply agreement to use MaxCyte's proprietary cell loading system to support clinical studies and commercializati...

Standard Networks to Distribute its Cryptographic Software in Japan and Taiwan

MADISON, Wis. - Standard Networks , a privately held software developer that creates secure data communication products and cryptographic software announced that Tokyo-based C4 Technologies a public security software developer has become the exclusive distributor for its MOVEit Crypto software in ...

Doyles Japan trip opens doors and minds for Wisconsin

Madison, Wis. The trade mission of Governor Jim Doyle and Wisconsin businesses to Japan has ended, and the verdict is mission accomplished. From September 25 to October 1, a team of 27 university and corporate representatives visited Japan to network with and tour Japanese industry, discu...

Wisconsin biotechs plan Japan trade mission

Madison, Wis. Wisconsin's life science companies have another chance to strengthen ties with Japan at an executive meeting held Friday at the MG&E Innovation Center. Sponsored by the Japan External Trade Organization , or JETRO, the gathering will offer attendees an inside look into how Wisc...

EraGen Expands in Japan

MADISON, WI. - EraGen Biosciences , a Wisconsin-based life science company that designs, develops and commercializes products and technologies that accelerate the drug discovery process, advance molecular diagnostics and functional proteomics announced today that it has selected ITOCHU Corporatio...

Third Wave Achieves Milestone, Delivers 200,000 SNP Assays to RIKEN In Japan

MADISON, Wis. -- Third Wave Technologies Inc. (Nasdaq: TWTI) today announced it delivered a total of 200,000 single nucleotide polymorphism (SNP) assays to RIKEN in Japan for use in various large scale genotyping projects. Since the beginning of 2003, Third Wave has been supplying its Invader ...

Doyle builds bridges and hopes for deals in Japan

A biotechnology trade mission to Japan is building interest in possible Wisconsin deals, Governor Jim Doyle said while sharing his experiences abroad in a conference call Monday morning. In Japan as part of a fact-finding mission with several Wisconsin representatives, Doyle has been speaking ...

ThermoGenesis Announces Expanded Collaboration With Celling Technologies

...the CE-Mark which allows sales of the product throughout the European community. Asahi Medical is the exclusive distributor for the CryoSeal System in japan and the Company markets through independent distributors in Europe and South America. This press release contains forward-looking...

ThermoGenesis Provides Update on Fiscal 2009 Results

...the CE-Mark which allows sales of the product throughout the European community. Asahi Medical is the exclusive distributor for the CryoSeal System in japan and the Company markets through independent distributors in Europe and South America. This press release contains forward-looking...

Keryx Biopharmaceuticals, Inc. Announces Second Quarter 2009 Financial Results

...primarily attributable to the recognition of $18.0 million in license revenue relating to an amendment to the September 2007 sublicense agreement with japan Tobacco Inc. and Torii Pharmaceutical Co., Ltd. (JT/Torii), which eliminated the Company's significant ongoing obligations included in the original ag...

NovaBay(R) Pharmaceuticals Names Roy J. Wu as Senior Vice President for Business Development

...uman Use (ICH), which brings together the regulatory authorities of Europe, japan and the United States and experts from the pharmaceutical industry in the t...tion of Pharmaceutical Science Requirements, the New York Pharma Forum, the japan Society of Northern California, the Healthcare Study Group (JETRO New York)...

R-Tech Ueno Notifies R&D Items

...veloped by R-Tech Ueno and is being developed as a drug indicated for male pattern alopecia. We intend to proceed with negotiations for affiliation in japan and abroad in the future. We also plan to newly develop this drug indicated for eyelash hypotrichosis. 5. Development code RTU-1096 (dermatolog...

Mylan Reports Adjusted Diluted EPS of $0.32 for the Quarter Ended June 30, 2009

... Sales in Asia Pacific are derived from Mylan's operations in Australia, japan and New Zealand. Asia Pacific revenues were $127.9 million in the current q...her in the current quarter. This increase was driven by higher revenues in japan as a result of continued pro-generic measures implemented by the Japanese g...

First genetically engineered malaria vaccine to enter human trials

...of the malaria parasite that will be used as a live vaccine against the disease. The vaccine, developed in collaboration with researchers from the US, japan and Canada, will be trialled in humans from early next year. Malaria kills more than one million people each year and destroys through premature de...

Sanofi-aventis Announces Second Quarter 2009 Results

... were up 9.1% at euro 3,482 million, with sales in japan up 73% at euro 155 million. On May 29, 2009...illion. Despite another good performance in japan (12.2% growth), Allegra ((R)) posted a slight d... ----- ----- ---- of which japan 442 +6.6% 952 +10.2% ...